Dermata Therapeutics's market cap is currently ―. The company's EPS TTM is $-3.983; its P/E ratio is -0.09; Dermata Therapeutics is scheduled to report earnings on May 13, 2024, and the estimated EPS forecast is $-0.36. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	$ -1.97M	$ -1.81M	$ -1.73M	$ -2.28M	$ -1.53M
EBITDA	$ -1.97M	$ -1.81M	$ -1.73M	$ -2.28M	$ -1.53M
Net Income Common Stockholders	$ -2.13M	$ -1.72M	$ -1.70M	$ -2.24M	$ -1.63M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 0.00	$ 6.63M	$ 8.44M	$ 8.77M	$ 6.24M
Total Assets	$ 7.98M	$ 7.32M	$ 8.71M	$ 9.30M	$ 6.94M
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Net Debt	$ 0.00	$ -6.63M	$ -8.44M	$ -8.77M	$ -6.24M
Total Liabilities	$ 1.62M	$ 916.82K	$ 682.86K	$ 1.21M	$ 922.63K
Stockholders Equity	$ 6.36M	$ 6.41M	$ 8.03M	$ 8.09M	$ 6.02M
Cash Flow	-
Free Cash Flow	$ -1.15M	$ -1.77M	$ -1.84M	$ -1.65M	$ -1.83M
Operating Cash Flow	$ -1.15M	$ -1.77M	$ -1.84M	$ -1.65M	$ -1.83M
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	$ 1.95M	$ -35.42K	$ 1.51M	$ 4.18M	-

Currency in USD

Dermata Therapeutics Earnings and Revenue History

Income Statement >

Dermata Therapeutics Debt to Assets

Balance Sheet >

Dermata Therapeutics Cash Flow

Cash Flow >

Dermata Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing